Ocular Therapeutix Inc (OCUL)
5.65
-0.19
(-3.25%)
USD |
NASDAQ |
May 10, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Stock Buybacks (Quarterly): -107.73M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -107.73M |
September 30, 2023 | -0.708M |
June 30, 2023 | -8.824M |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | -161.98M |
September 30, 2020 | 0.318M |
June 30, 2020 | -50.34M |
March 31, 2020 | -12.69M |
December 31, 2019 | -8.89M |
September 30, 2019 | -18.58M |
June 30, 2019 | -5.114M |
Date | Value |
---|---|
March 31, 2019 | -4.954M |
December 31, 2018 | -5.61M |
September 30, 2018 | -12.84M |
June 30, 2018 | -8.128M |
March 31, 2018 | -34.99M |
December 31, 2017 | -0.581M |
September 30, 2017 | -1.585M |
June 30, 2017 | -0.80M |
March 31, 2017 | -26.27M |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.034M |
June 30, 2015 | -65.65M |
March 31, 2015 | |
December 31, 2014 | 0.00 |
September 30, 2014 | -69.52M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-161.98M
Minimum
Dec 2020
0.318M
Maximum
Sep 2020
-28.81M
Average
-8.824M
Median
Jun 2023
Stock Buybacks (Quarterly) Benchmarks
Amgen Inc | -- |
Assertio Holdings Inc | -- |
CytomX Therapeutics Inc | -- |
EyePoint Pharmaceuticals Inc | -216.20M |
Regeneron Pharmaceuticals Inc | -47.10M |